Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant in Patients With Sleep Disturbance and Hepatic Encephalopathy
NCT07830303Phase 4Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 4 trial of daridorexant in sleep disorder, hepatic encephalopathy (HE). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
daridorexant
03
Conditions
sleep disorderhepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT07830303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830303.